Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer

被引：0
作者：
Yoshiki Hirooka
Takuya Ishikawa
Hiroki Kawashima
Eizaburo Ohno
Koji Nonogaki
Akira Kanamori
Takanori Hirai
Hiroki Uchida
Osamu Shirai
Hideki Ishikawa
Hidemi Goto
机构：
[1] Nagoya University Hospital,Department of Endoscopy
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterology
[3] Daido Hospital,Department of Gastroenterology
[4] Ogaki Municipal Hospital,Department of Gastroenterology
[5] Komaki City Hospital,Department of Gastroenterology
[6] Okazaki City Hospital,Department of Gastroenterology
[7] Toki General Hospital,Department of Gastroenterology
[8] Tokai Central Hospital,Department of Gastroenterology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Gemcitabine; Cisplatin; Gallbladder cancer; Unresectable; Prospective study; Multicenter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：119 / 125
页数：6
相关论文
共 50 条
[31]   Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer [J].
De Lange, SM ;
van Groeningen, CJ ;
Kroep, JR ;
Van Bochove, A ;
Snijders, JF ;
Peters, GJ ;
Pinedo, HM ;
Giaccone, G .
ANNALS OF ONCOLOGY, 2004, 15 (03) :484-488
[32]   Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer:: A randomized phase II study [J].
Dueñas-González, A ;
Cetina-Perez, L ;
Lopez-Graniel, C ;
Gonzalez-Enciso, A ;
Gómez-Gonzalez, E ;
Rivera-Rubi, L ;
Montalvo-Esquivel, G ;
Muñoz-Gonzalez, D ;
Robles-Flores, J ;
Vazquez-Govea, E ;
De La Garza, J ;
Mohar, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (03) :817-823
[33]   Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer [J].
Koizumi, W ;
Fukuyama, Y ;
Fukuda, T ;
Akiya, T ;
Hasegawa, K ;
Kojima, Y ;
Ohn, N ;
Kurihara, M .
ANTICANCER RESEARCH, 2004, 24 (04) :2465-2470
[34]   Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder [J].
Malik, IA ;
Aziz, Z ;
Zaidi, SHM ;
Sethuraman, G .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02) :174-177
[35]   Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer [J].
Yun Fan ;
Neng-ming Lin ;
Sheng-lin Ma ;
Lü-hong Luo ;
Luo Fang ;
Zhi-yu Huang ;
Hai-feng Yu ;
Feng-qin Wu .
Acta Pharmacologica Sinica, 2010, 31 :746-752
[36]   Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer [J].
Fan, Yun ;
Lin, Neng-ming ;
Ma, Sheng-lin ;
Luo, Lue-hong ;
Fang, Luo ;
Huang, Zhi-yu ;
Yu, Hai-feng ;
Wu, Feng-qin .
ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) :746-752
[37]   Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer [J].
De Marinis, F ;
Migliorino, MR ;
Paoluzzi, L ;
Portalone, L ;
Ariganello, O ;
Cortesi, E ;
Gamucci, T ;
Gasperoni, S ;
Cipri, A ;
Martelli, O ;
Nelli, F .
LUNG CANCER, 2003, 39 (03) :331-338
[38]   A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer [J].
Basil F. El-Rayes ;
Mark M. Zalupski ;
Anthony F. Shields ;
Ann Marie Ferris ;
Ulka Vaishampayan ;
Lance K. Heilbrun ;
Raghu Venkatramanamoorthy ;
Volkan Adsay ;
Philip A. Philip .
Investigational New Drugs, 2005, 23 :583-590
[39]   A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer [J].
El-Rayes, BF ;
Zalupski, MM ;
Shields, AF ;
Ferris, AM ;
Vaishampayan, U ;
Heilbrun, LK ;
Venkatramanamoorthy, R ;
Adsay, V ;
Philip, PA .
INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) :583-590
[40]   Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer [J].
Park, Byung Kyu ;
Kim, Yoon Jae ;
Park, Jeong Youp ;
Bang, Seungmin ;
Park, Seung Woo ;
Chung, Jae Bock ;
Kim, Kyung Sik ;
Choi, Jin-Sub ;
Lee, Woo Jung ;
Song, Si Young .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) :999-1003
12345